Works matching IS 15391604 AND DT 2025 AND VI 24 AND IP 2

Results: 32

Average Hazard as Harmonic Mean.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.70009

By:

Chiba, Yasutaka

Publication type:

Article

Using Subject Level Covariate Information in Bayesian Mixture Models for Basket Trials.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.70006

By:

Govande, Sneha;
Slate, Elizabeth H.

Publication type:

Article

Success and Futility Criteria for Accelerated Approval of Oncology Drugs.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.70004

By:

Xi, Dong;
Gou, Jiangtao

Publication type:

Article

A Federated Data Analysis Approach for the Evaluation of Surrogate Endpoints.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.70003

By:

De Witte, Dries;
Abad, Ariel Alonso;
Stephenson, Diane;
Karten, Yashmin;
Leuzy, Antoine;
Klein, Gregory;
Molenberghs, Geert

Publication type:

Article

Interval Estimation for the Youden Index and Optimal Cut‐Off Point in AUC‐Based Optimal Combinations of Multivariate Normal Biomarkers With Covariates.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.70001

By:

Nadeb, Hossein;
Zhao, Yichuan

Publication type:

Article

Getting (More Out of) Graphics—Practices and Principles of Data Visualisation. Data Science Series.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.70000

By:

Zhao, Wei

Publication type:

Article

Approximate Bayesian Analysis for Borrowing External Controls for Randomized Controlled Trials With Dynamic Borrowing and Covariate Balancing Adjustment.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2474

By:

Wang, Jixian;
Tiwari, Ram

Publication type:

Article

Trial Probability of Success for Testing 3‐Way PK/PD Similarity With Multiple Endpoints.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2473

By:

el Galta, Rachid;
Schmitt, Susanne;
Arani, Ramin;
Ring, Arne

Publication type:

Article

Estimation Methods for Estimands Using the Treatment Policy Strategy; a Simulation Study Based on the PIONEER 1 Trial.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2472

By:

Bell, James;
Drury, Thomas;
Mütze, Tobias;
Pipper, Christian Bressen;
Guizzaro, Lorenzo;
Mitroiu, Marian;
Rantell, Khadija Rerhou;
Wolbers, Marcel;
Wright, David

Publication type:

Article

Using Propensity Score Weighting to Enhance the Operating Characteristics of Power Prior in Leveraging External Data to Augment a Traditional Clinical Study.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2471

By:

Li, Heng;
Chen, Wei‐Chen;
Wang, Chenguang;
Lu, Nelson;
Song, Changhong;
Tiwari, Ram;
Alexander, Gregory;
Xu, Yunling;
Yue, Lilly Q.

Publication type:

Article

BF‐BOIN‐ET: A Backfill Bayesian Optimal Interval Design Using Efficacy and Toxicity Outcomes for Dose Optimization.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2470

By:

Takeda, Kentaro;
Zhu, Jing;
Hirakawa, Akihiro

Publication type:

Article

Real Effect or Bias? Good Practices for Evaluating the Robustness of Evidence From Comparative Observational Studies Through Quantitative Sensitivity Analysis for Unmeasured Confounding.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2457

By:

Faries, Douglas;
Gao, Chenyin;
Zhang, Xiang;
Hazlett, Chad;
Stamey, James;
Yang, Shu;
Ding, Peng;
Shan, Mingyang;
Sheffield, Kristin;
Dreyer, Nancy

Publication type:

Article

WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2463

By:

Sechidis, Konstantinos;
Sun, Sophie;
Chen, Yao;
Lu, Jiarui;
Zhang, Cong;
Baillie, Mark;
Ohlssen, David;
Vandemeulebroecke, Marc;
Hemmings, Rob;
Ruberg, Stephen;
Bornkamp, Björn

Publication type:

Article

A Phase I Dose‐Finding Design Incorporating Intra‐Patient Dose Escalation.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2461

By:

Guo, Beibei;
Liu, Suyu

Publication type:

Article

Flexible Spline Models for Blinded Sample Size Reestimation in Event‐Driven Clinical Trials.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2459

By:

Mori, Tim;
Komukai, Sho;
Hattori, Satoshi;
Friede, Tim

Publication type:

Article

Confidence Intervals for the Risk Difference Between Secondary and Primary Infection Based on the Method of Variance Estimates Recovery.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2458

By:

Chen, Chao;
Li, Yuanzhen;
Wei, Qitong;
Huang, Zhigang;
Chen, Yanting

Publication type:

Article

A Bayesian Hybrid Design With Borrowing From Historical Study.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2466

By:

Lu, Zhaohua;
Toso, John;
Ayele, Girma;
He, Philip

Publication type:

Article

A Bayesian Dynamic Model‐Based Adaptive Design for Oncology Dose Optimization in Phase I/II Clinical Trials.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2451

By:

Qiu, Yingjie;
Li, Mingyue

Publication type:

Article

Subgroup Identification Based on Quantitative Objectives.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2455

By:

Sun, Yan;
Hedayat, A. S.

Publication type:

Article

A Model‐Based Trial Design With a Randomization Scheme Considering Pharmacokinetics Exposure for Dose Optimization in Oncology.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2454

By:

Zhang, Jun;
Takeda, Kentaro;
Takeuchi, Masato;
Komatsu, Kanji;
Zhu, Jing;
Yamaguchi, Yusuke

Publication type:

Article

Potential Bias Models With Bayesian Shrinkage Priors for Dynamic Borrowing of Multiple Historical Control Data.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2453

By:

Ohigashi, Tomohiro;
Maruo, Kazushi;
Sozu, Takashi;
Sawamoto, Ryo;
Gosho, Masahiko

Publication type:

Article

Beyond the Fragility Index.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2452

By:

Quatto, Piero;
Ripamonti, Enrico;
Marasini, Donata

Publication type:

Article

Bayesian Solutions for Assessing Differential Effects in Biomarker Positive and Negative Subgroups.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2456

By:

Jackson, Dan;
Zhang, Fanni;
Burman, Carl‐Fredrik;
Sharples, Linda

Publication type:

Article

Pre‐Posterior Distributions in Drug Development and Their Properties.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2450

By:

Grieve, Andrew P.

Publication type:

Article

Treatment Effect Measures Under Nonproportional Hazards.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2449

By:

Jackson, Dan;
Sweeting, Michael;
Baker, Rose

Publication type:

Article

Comparison of Prior Distributions for the Heterogeneity Parameter in a Rare Events Meta‐Analysis of a Few Studies.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2448

By:

Yao, Minghong;
Mei, Fan;
Zou, Kang;
Li, Ling;
Sun, Xin

Publication type:

Article

Prediction Intervals for Overdispersed Poisson Data and Their Application in Medical and Pre‐Clinical Quality Control.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2447

By:

Menssen, Max;
Dammann, Martina;
Fneish, Firas;
Ellenberger, David;
Schaarschmidt, Frank

Publication type:

Article

Optimizing Sample Size Determinations for Phase 3 Clinical Trials in Type 2 Diabetes.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2446

By:

Cambon, Alexander C.;
Travis, James;
Sun, Liping;
Idokogi, Jada;
Kettermann, Anna

Publication type:

Article

A Likelihood Perspective on Dose‐Finding Study Designs in Oncology.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2445

By:

Zhang, Zhiwei

Publication type:

Article

PKBOIN‐12: A Bayesian Optimal Interval Phase I/II Design Incorporating Pharmacokinetics Outcomes to Find the Optimal Biological Dose.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2444

By:

Sun, Hao;
Tu, Jieqi

Publication type:

Article

Bayesian Response Adaptive Randomization for Randomized Clinical Trials With Continuous Outcomes: The Role of Covariate Adjustment.

Published in:

Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2443

By:

Aslanyan, Vahan;
Pickering, Trevor;
Nuño, Michelle;
Renfro, Lindsay A.;
Pa, Judy;
Mack, Wendy J.

Publication type:

Article

Issue Information.

Published in:: Pharmaceutical Statistics, 2025, v. 24, n. 2, p. 1, doi. 10.1002/pst.2401
Publication type:: Article